Search Results 471-480 of 17113 for pharmacogenetics
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
This clinical trial is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies. Developing a way to track ...
The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...
Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...
About this study. RATIONALE: Interferon alfa may interfere with the growth of cancer cells. It is not yet known whether treatment with interferon alfa is ...
Overview · High-throughput systems to identify cell-targeting ligands to target drugs, diagnostics, vaccines and gene delivery vectors. · Developing genetic and ...
Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...
The purpose of this study is to quantify the burden of biological aging and CH in patients with autoimmune diseases undergoing AHCT. Assess the impact of AHCT ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
This liver condition usually runs in families. It causes your body to absorb too much iron from the foods you eat. Learn about symptoms, causes and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!